Chengdu Kanghong Pharmaceuticals Group Co Ltd Strategic Asset Allocation Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd strategic asset allocation index. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Strategic Asset Allocation Index of 32.0% as of September 2023. Strategic assets (PP&E of CN¥2.43 Billion plus long-term investments of CN¥-) total CN¥2.43 Billion, measured against net assets of CN¥7.60 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Chengdu Kanghong Pharmaceuticals Group C net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2011–2021)
Strategic asset allocation index of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2011 to 2021. This chart shows how Chengdu Kanghong Pharmaceuticals Group Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of September 2023, the index stands at 32.0%, representing strategic assets of CN¥2.43 Billion against net assets of CN¥7.60 Billion CNY. Check Chengdu Kanghong Pharmaceuticals Group C tangible book value ratio to evaluate the tangible quality of the company's equity base.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Strategic Asset Allocation Index by Year (2011–2021)
Chengdu Kanghong Pharmaceuticals Group Co Ltd strategic asset allocation index by year from 2011 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Chengdu Kanghong Pharmaceuticals Group C (002773) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 34.4% | CN¥2.10 Billion | CN¥2.10 Billion | CN¥- | CN¥6.10 Billion | ▲ +3.4 pp |
| 2020 | 30.9% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥5.76 Billion | ▲ +3.4 pp |
| 2019 | 27.6% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥4.62 Billion | ▲ +6.8 pp |
| 2018 | 20.8% | CN¥849.08 Million | CN¥839.58 Million | CN¥9.50 Million | CN¥4.08 Billion | ▲ +2.0 pp |
| 2017 | 18.8% | CN¥664.75 Million | CN¥664.75 Million | CN¥- | CN¥3.54 Billion | ▲ +0.3 pp |
| 2016 | 18.5% | CN¥537.59 Million | CN¥537.59 Million | CN¥- | CN¥2.90 Billion | ▼ -1.3 pp |
| 2015 | 19.8% | CN¥500.78 Million | CN¥500.78 Million | CN¥- | CN¥2.52 Billion | ▼ -10.4 pp |
| 2014 | 30.2% | CN¥487.11 Million | CN¥487.11 Million | CN¥- | CN¥1.61 Billion | ▼ -5.6 pp |
| 2013 | 35.8% | CN¥498.04 Million | CN¥498.04 Million | CN¥- | CN¥1.39 Billion | ▼ -11.6 pp |
| 2012 | 47.5% | CN¥524.95 Million | CN¥524.95 Million | CN¥- | CN¥1.11 Billion | ▼ -4.5 pp |
| 2011 | 51.9% | CN¥486.33 Million | CN¥486.33 Million | CN¥- | CN¥936.39 Million | — |